Fate of cost-saving biosimilar drugs may hinge on naming policy

Saturday, July 4, 2015

Source: Modern Healthcare

What's in a name?

A lot, according to groups battling over whether biosimilar pharmaceutical products should be allowed to use the same nonproprietary name as branded products.

View All News »